Cargando…

Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders

[Image: see text] Grape seed extract (GSE) is rich in flavonoids and has been recognized to possess human health benefits. Our group and others have demonstrated that GSE is able to attenuate the development of Alzheimer’s disease (AD). Moreover, our results have disclosed that the anti-Alzheimer’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Docampo-Palacios, Maite L., Alvarez-Hernández, Anislay, de Fátima, Ângelo, Lião, Luciano Morais, Pasinetti, Giulio M., Dixon, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689943/
https://www.ncbi.nlm.nih.gov/pubmed/33251444
http://dx.doi.org/10.1021/acsomega.0c04512
_version_ 1783613966632615936
author Docampo-Palacios, Maite L.
Alvarez-Hernández, Anislay
de Fátima, Ângelo
Lião, Luciano Morais
Pasinetti, Giulio M.
Dixon, Richard A.
author_facet Docampo-Palacios, Maite L.
Alvarez-Hernández, Anislay
de Fátima, Ângelo
Lião, Luciano Morais
Pasinetti, Giulio M.
Dixon, Richard A.
author_sort Docampo-Palacios, Maite L.
collection PubMed
description [Image: see text] Grape seed extract (GSE) is rich in flavonoids and has been recognized to possess human health benefits. Our group and others have demonstrated that GSE is able to attenuate the development of Alzheimer’s disease (AD). Moreover, our results have disclosed that the anti-Alzheimer’s benefits are not directly/solely related to the dietary flavonoids themselves, but rather to their metabolites, particularly to the glucuronidated ones. To facilitate the understanding of regioisomer/stereoisomer-specific biological effects of (epi)catechin glucuronides, we here describe a concise chemical synthesis of authentic standards of catechin and epicatechin metabolites 3–12. The synthesis of glucuronides 9 and 12 is described here for the first time. The key reactions employed in the synthesis of the novel glucuronides 9 and 12 include the regioselective methylation of the 4′-hydroxyl group of (epi)catechin (≤1.0/99.0%; 3′-OMe/4′-OMe) and the regioselective deprotection of the tert-butyldimethylsilyl (TBS) group at position 5 (yielding up to 79%) over the others (3, 7 and 3′ or 4′).
format Online
Article
Text
id pubmed-7689943
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-76899432020-11-27 Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders Docampo-Palacios, Maite L. Alvarez-Hernández, Anislay de Fátima, Ângelo Lião, Luciano Morais Pasinetti, Giulio M. Dixon, Richard A. ACS Omega [Image: see text] Grape seed extract (GSE) is rich in flavonoids and has been recognized to possess human health benefits. Our group and others have demonstrated that GSE is able to attenuate the development of Alzheimer’s disease (AD). Moreover, our results have disclosed that the anti-Alzheimer’s benefits are not directly/solely related to the dietary flavonoids themselves, but rather to their metabolites, particularly to the glucuronidated ones. To facilitate the understanding of regioisomer/stereoisomer-specific biological effects of (epi)catechin glucuronides, we here describe a concise chemical synthesis of authentic standards of catechin and epicatechin metabolites 3–12. The synthesis of glucuronides 9 and 12 is described here for the first time. The key reactions employed in the synthesis of the novel glucuronides 9 and 12 include the regioselective methylation of the 4′-hydroxyl group of (epi)catechin (≤1.0/99.0%; 3′-OMe/4′-OMe) and the regioselective deprotection of the tert-butyldimethylsilyl (TBS) group at position 5 (yielding up to 79%) over the others (3, 7 and 3′ or 4′). American Chemical Society 2020-11-12 /pmc/articles/PMC7689943/ /pubmed/33251444 http://dx.doi.org/10.1021/acsomega.0c04512 Text en © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Docampo-Palacios, Maite L.
Alvarez-Hernández, Anislay
de Fátima, Ângelo
Lião, Luciano Morais
Pasinetti, Giulio M.
Dixon, Richard A.
Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
title Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
title_full Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
title_fullStr Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
title_full_unstemmed Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
title_short Efficient Chemical Synthesis of (Epi)catechin Glucuronides: Brain-Targeted Metabolites for Treatment of Alzheimer’s Disease and Other Neurological Disorders
title_sort efficient chemical synthesis of (epi)catechin glucuronides: brain-targeted metabolites for treatment of alzheimer’s disease and other neurological disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689943/
https://www.ncbi.nlm.nih.gov/pubmed/33251444
http://dx.doi.org/10.1021/acsomega.0c04512
work_keys_str_mv AT docampopalaciosmaitel efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders
AT alvarezhernandezanislay efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders
AT defatimaangelo efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders
AT liaolucianomorais efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders
AT pasinettigiuliom efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders
AT dixonricharda efficientchemicalsynthesisofepicatechinglucuronidesbraintargetedmetabolitesfortreatmentofalzheimersdiseaseandotherneurologicaldisorders